Crossmark

Inhalation cancer risk assessment of hexavalent chromium based on updated mortality for Painesville chromate production workers

Crossref DOI link: https://doi.org/10.1038/jes.2015.77

Published Online: 2015-12-16

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Proctor, Deborah M

Suh, Mina

Mittal, Liz

Hirsch, Shawn

Valdes Salgado, Raydel

Bartlett, Chris

Van Landingham, Cynthia

Rohr, Annette

Crump, Kenny
License Information

Text and Data Mining valid from 2015-12-16
More Information

Article History

Received: 19 May 2015

Revised: 8 October 2015

Accepted: 13 October 2015

First Online: 16 December 2015

Competing interests

: This work was funded by the Electric Power Research Institute (EPRI), an independent non-profit 501(c)3 organization that funds external research at a number of universities and institutes worldwide. EPRI researcher and co-author, Dr. Annette Rohr, was given the opportunity to review the final draft manuscript. The purpose of the review was to allow input on the clarity of the science presented but not in interpretation of the research findings. DP, MS, and LM are employees of ToxStrategies. ToxStrategies is a private consulting firm providing services to private and public organizations on toxicology and risk assessment issues. DP and MS have presented study findings in meetings with regulators including public meetings on behalf of EPRI. DP has also been an expert in litigation involving Cr(VI). SH, RVS, CB, CVL, and KC are independent contractors to ToxStrategies and have no conflict of interest.